227 related articles for article (PubMed ID: 30923586)
1. Economic Analysis of Batch and Continuous Biopharmaceutical Antibody Production: A Review.
Yang O; Qadan M; Ierapetritou M
J Pharm Innov; 2019; 14():1-19. PubMed ID: 30923586
[TBL] [Abstract][Full Text] [Related]
2. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
Garcia FA; Vandiver MW
PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
[TBL] [Abstract][Full Text] [Related]
3. Fully integrated downstream process to enable next-generation manufacturing.
Ramos I; Sharda N; Villafana R; Hill-Byrne K; Cai K; Pezzini J; Coffman J
Biotechnol Bioeng; 2023 Jul; 120(7):1869-1881. PubMed ID: 36950907
[TBL] [Abstract][Full Text] [Related]
4. Process design of a fully integrated continuous biopharmaceutical process using economic and ecological impact assessment.
Ding C; Ardeshna H; Gillespie C; Ierapetritou M
Biotechnol Bioeng; 2022 Dec; 119(12):3567-3583. PubMed ID: 36109341
[TBL] [Abstract][Full Text] [Related]
5. Continuous counter-current chromatography for capture and polishing steps in biopharmaceutical production.
Steinebach F; Müller-Späth T; Morbidelli M
Biotechnol J; 2016 Sep; 11(9):1126-41. PubMed ID: 27376629
[TBL] [Abstract][Full Text] [Related]
6. Evaluating end-to-end continuous antibody manufacture with column-free capture alternatives from economic, environmental, and robustness perspectives.
Neves CPG; Coffman JL; Farid SS
Biotechnol Prog; 2024 Jan; ():e3427. PubMed ID: 38289674
[TBL] [Abstract][Full Text] [Related]
7. Implementation of Fully Integrated Continuous Antibody Processing: Effects on Productivity and COGm.
Arnold L; Lee K; Rucker-Pezzini J; Lee JH
Biotechnol J; 2019 Feb; 14(2):e1800061. PubMed ID: 29729129
[TBL] [Abstract][Full Text] [Related]
8. Economic assessment of continuous processing for manufacturing of biotherapeutics.
Gupta P; Kateja N; Mishra S; Kaur H; Rathore AS
Biotechnol Prog; 2021 Mar; 37(2):e3108. PubMed ID: 33305493
[TBL] [Abstract][Full Text] [Related]
9. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in continuous and semi-continuous processing of solid oral dosage forms: a review.
Teżyk M; Milanowski B; Ernst A; Lulek J
Drug Dev Ind Pharm; 2016 Aug; 42(8):1195-214. PubMed ID: 26592545
[TBL] [Abstract][Full Text] [Related]
11. Enablers of continuous processing of biotherapeutic products.
Rathore AS; Zydney AL; Anupa A; Nikita S; Gangwar N
Trends Biotechnol; 2022 Jul; 40(7):804-815. PubMed ID: 35034769
[TBL] [Abstract][Full Text] [Related]
12. A systematic techno-economic approach to decide between continuous and batch operation modes for injectable manufacturing.
Yamada M; Badr S; Udugama IA; Fukuda S; Nakaya M; Yoshioka Y; Sugiyama H
Int J Pharm; 2022 Feb; 613():121353. PubMed ID: 34896214
[TBL] [Abstract][Full Text] [Related]
13. Integrated two-liquid phase bioconversion and product-recovery processes for the oxidation of alkanes: process design and economic evaluation.
Mathys RG; Schmid A; Witholt B
Biotechnol Bioeng; 1999 Aug; 64(4):459-77. PubMed ID: 10397885
[TBL] [Abstract][Full Text] [Related]
14. Economic simulation of batch and continuous aqueous two-phase purification for viral products.
Nold NM; Pearson E; Heldt CL
Biotechnol Prog; 2024; 40(1):e3397. PubMed ID: 37843875
[TBL] [Abstract][Full Text] [Related]
15. Control Systems Engineering in Continuous Pharmaceutical Manufacturing May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-839. PubMed ID: 28756845
[TBL] [Abstract][Full Text] [Related]
16. Reducing biopharmaceutical manufacturing costs through continuous processing in a flexible J.POD® facility.
Garcia FA; Gefroh E
Drug Discov Today; 2023 Jul; 28(7):103619. PubMed ID: 37201779
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds.
Cole KP; Johnson MD
Expert Rev Clin Pharmacol; 2018 Jan; 11(1):5-13. PubMed ID: 29206489
[TBL] [Abstract][Full Text] [Related]
19. Converting a mAb downstream process from batch to continuous using process modeling and process analytical technology.
Chen R; Chen XJ; Shi C; Jiao B; Shi Y; Yao B; Lin DQ; Gong W; Hsu S
Biotechnol J; 2022 Nov; 17(11):e2100351. PubMed ID: 35908168
[TBL] [Abstract][Full Text] [Related]
20. Continuous bind-and-elute protein A capture chromatography: Optimization under process scale column constraints and comparison to batch operation.
Kaltenbrunner O; Diaz L; Hu X; Shearer M
Biotechnol Prog; 2016 Jul; 32(4):938-48. PubMed ID: 27111828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
